Repligen Corp Net Income per Employee (RGEN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Repligen Corp  (NASDAQ: RGEN)
 

Repligen Net Income per Employee

RGEN's Quarterly Results, Trends, Rankings, Statistics
Repligen's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 20,770, below the company average number of $21,744.
The Healthcare sector has seen employees of 21 other companies achieving higher income per employee. While Repligen's total ranking has deteriorated compared to the previous quarter from 1150 to 1689.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGEN Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change -66.31 % 42.93 % - - 160.21 %
Net Income per Employee (TTM) $ 20,770 25,699 24,447 869 -6,914
RGEN's Total Ranking # 1689 # 1150 # 1609 # 2157 # 1540
Seq. Net Income Change -39.9 % -37.28 % -10.89 % 0.3 % 154.99 %

RGEN Company Profile >> Back to RGEN Efficiency Comparisons >> Compare RGEN Net Income per Employee to its Competitors

RGEN Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 22
Healthcare Sector # 143
Overall Market # 1689

Net Income per Employee Statistics
High Average Low
$ 92,980 $ 21,744 $ -12,757
(Dec 31 2022)   (Dec 31 2024)




  News about Repligen Corp Income per employee

Repligen's Private Convertible Transaction Marks a $600 Million Milestone, Strengthening Financial Position and Driving Growth

Repligen Corporation, a leading biotechnology and pharmaceutical company, has recently made a significant announcement regarding a private convertible transaction. On December 6, 2023, Repligen entered into privately negotiated exchange and subscription agreements with specific holders of its outstanding 0.375% Convertible Senior Notes due 2024 (the 2024 Notes) as well as new investors. This transaction will allow Repligen to issue $600 million worth of 1.00% Convertible Senior Notes due 2028 (the New Notes).
Under these agreements, approximately $309.9 million principal amount of the New Notes will be exchanged for around $217.7 million principal amount of the 2024 Notes. Moreover, approximately $290.1 million principal amount of the New Notes will be issued for cash. Collectively, these transactions, known as the Exchange Transactions and Subscription Transactions, reveal Repligen s strategic effort to optimize its financial position.




Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Alkermes Plc   32,255.12 $ 66.123  Million 2,050 
Tenet Healthcare Corp  32,060.61 $ 3,174.000  Million 99,000 
Haemonetics Corporation  31,851.47 $ 96.287  Million 3,023 
Pacific Health Care Organization Inc  31,571.29 $ 0.979  Million 31 
Bio rad Laboratories Inc   29,852.35 $ 222.400  Million 7,450 
Privia Health Group Inc   27,598.69 $ 33.836  Million 1,226 
Pediatrix Medical Group Inc   26,667.58 $ 174.806  Million 6,555 
Amneal Pharmaceuticals Inc   25,331.65 $ 215.319  Million 8,500 
Nature s Sunshine Products inc   23,205.96 $ 18.704  Million 806 
Tactile Systems Technology Inc   22,895.95 $ 24.865  Million 1,086 
Lifevantage Corp  22,744.39 $ 5.072  Million 223 
Biomarin Pharmaceutical Inc  22,655.08 $ 72.972  Million 3,221 
Revvity Inc  21,595.82 $ 237.554  Million 11,000 
Waters Corporation  21,030.00 $ 166.137  Million 7,900 
Teva Pharmaceutical Industries Limited  20,883.65 $ 709.000  Million 33,950 
Repligen Corp  20,769.50 $ 41.539  Million 2,000 
Encompass Health Corporation  19,840.48 $ 833.300  Million 42,000 
Quest Diagnostics Inc  19,526.32 $ 1,113.000  Million 57,000 
Infusystem Holdings Inc  18,061.31 $ 8.543  Million 473 
Pacira Biosciences inc   17,657.42 $ 14.638  Million 829 
Chemed Corporation  17,392.51 $ 274.993  Million 15,811 
Henry Schein Inc   17,040.00 $ 426.000  Million 25,000 
Nrc Health  16,350.14 $ 5.837  Million 357 
Concentra Group Holdings Parent Inc   15,815.69 $ 205.604  Million 13,000 
Brightspring Health Services Inc   15,548.09 $ 365.380  Million 23,500 
Universal Health Services Inc   15,273.00 $ 1,550.210  Million 101,500 
Davita Inc   15,250.49 $ 1,189.538  Million 78,000 
Ufp Technologies Inc   14,918.49 $ 72.295  Million 4,846 
Conmed Corporation  14,486.41 $ 56.497  Million 3,900 
Becton Dickinson And Company  13,069.44 $ 941.000  Million 72,000 


Date modified: 2026-08-12T20:46:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.